Cargando…

A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia

INTRODUCTION: A neutrophilic infiltrate characterizes bacterial pneumonia. Macrophage infiltration is similarly characteristic of the viral pneumonia caused by SARS‐CoV‐2. These infiltrating macrophages, while phagocytic and capable of engulfing virus laden alveolar cells, are also rich in tissue fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bull, Brian S., Hay, Karen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427003/
https://www.ncbi.nlm.nih.gov/pubmed/34231951
http://dx.doi.org/10.1002/iid3.482
_version_ 1783750117852971008
author Bull, Brian S.
Hay, Karen L.
author_facet Bull, Brian S.
Hay, Karen L.
author_sort Bull, Brian S.
collection PubMed
description INTRODUCTION: A neutrophilic infiltrate characterizes bacterial pneumonia. Macrophage infiltration is similarly characteristic of the viral pneumonia caused by SARS‐CoV‐2. These infiltrating macrophages, while phagocytic and capable of engulfing virus laden alveolar cells, are also rich in tissue factor—a thromboplastin. This prothrombotic aspect likely explains how a respiratory virus whose malign effects should be confined to the oropharynx, bronchi and lungs, can cause a panoply of extra‐pulmonary organ disorders. Elevated ferritin levels in ICU Covid 19 patients, and elevated acute phase proteins suggest immune overreaction. Elevated d‐dimers implicate clotting as well. This evidence links hyperactive innate immunity (macrophage lung infiltrates) with the elevated levels of oligomeric fibrin present in the bloodstream of these patients. METHODS: An in‐house assay measuring oligomeric (soluble) fibrin (also referred to as soluble fibrin monomer complexes or SFMC) in whole blood, previously developed for monitoring incipient disseminated intravascular coagulation (DIC) during liver transplantation, was made available to COVID ICU attendings. Since SFMC constitutes the input to intravascular fibrin clots and d‐dimer reflects fibrin clot dissolution, it was thought that the two tests, run in tandem along with assays of immune activation, might clarify the frequency and possibly the cause of DIC in patients with severe COVID‐19 pneumonia. RESULTS: Classical DIC with intravascular clotting and thrombocytopenia was documented only rarely. However, early in the pandemic shortly after the assay was made available, it identified three patients undergoing acute defibrination. In each patient virtually all of the body's fibrinogen was transformed into SFMC over 3–4 days and deposited somewhere in the vasculature without any gross clots being detected. CONCLUSIONS: Three COVID‐19 patients with evidence of a hyperactive immune response (elevated ferritin and acute phase proteins) defibrinated while blood levels of SFMC were being monitored. SFMC levels that were five times higher than normal appeared in the circulation during the defibrination process. SFMC at these levels may precipitate as showers of microclots, damaging heart, kidney, brain, and so forth.
format Online
Article
Text
id pubmed-8427003
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84270032021-09-09 A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia Bull, Brian S. Hay, Karen L. Immun Inflamm Dis Original Articles INTRODUCTION: A neutrophilic infiltrate characterizes bacterial pneumonia. Macrophage infiltration is similarly characteristic of the viral pneumonia caused by SARS‐CoV‐2. These infiltrating macrophages, while phagocytic and capable of engulfing virus laden alveolar cells, are also rich in tissue factor—a thromboplastin. This prothrombotic aspect likely explains how a respiratory virus whose malign effects should be confined to the oropharynx, bronchi and lungs, can cause a panoply of extra‐pulmonary organ disorders. Elevated ferritin levels in ICU Covid 19 patients, and elevated acute phase proteins suggest immune overreaction. Elevated d‐dimers implicate clotting as well. This evidence links hyperactive innate immunity (macrophage lung infiltrates) with the elevated levels of oligomeric fibrin present in the bloodstream of these patients. METHODS: An in‐house assay measuring oligomeric (soluble) fibrin (also referred to as soluble fibrin monomer complexes or SFMC) in whole blood, previously developed for monitoring incipient disseminated intravascular coagulation (DIC) during liver transplantation, was made available to COVID ICU attendings. Since SFMC constitutes the input to intravascular fibrin clots and d‐dimer reflects fibrin clot dissolution, it was thought that the two tests, run in tandem along with assays of immune activation, might clarify the frequency and possibly the cause of DIC in patients with severe COVID‐19 pneumonia. RESULTS: Classical DIC with intravascular clotting and thrombocytopenia was documented only rarely. However, early in the pandemic shortly after the assay was made available, it identified three patients undergoing acute defibrination. In each patient virtually all of the body's fibrinogen was transformed into SFMC over 3–4 days and deposited somewhere in the vasculature without any gross clots being detected. CONCLUSIONS: Three COVID‐19 patients with evidence of a hyperactive immune response (elevated ferritin and acute phase proteins) defibrinated while blood levels of SFMC were being monitored. SFMC levels that were five times higher than normal appeared in the circulation during the defibrination process. SFMC at these levels may precipitate as showers of microclots, damaging heart, kidney, brain, and so forth. John Wiley and Sons Inc. 2021-07-07 /pmc/articles/PMC8427003/ /pubmed/34231951 http://dx.doi.org/10.1002/iid3.482 Text en © 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Bull, Brian S.
Hay, Karen L.
A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia
title A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia
title_full A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia
title_fullStr A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia
title_full_unstemmed A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia
title_short A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia
title_sort macrophage attack culminating in microthromboses characterizes covid 19 pneumonia
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427003/
https://www.ncbi.nlm.nih.gov/pubmed/34231951
http://dx.doi.org/10.1002/iid3.482
work_keys_str_mv AT bullbrians amacrophageattackculminatinginmicrothrombosescharacterizescovid19pneumonia
AT haykarenl amacrophageattackculminatinginmicrothrombosescharacterizescovid19pneumonia
AT bullbrians macrophageattackculminatinginmicrothrombosescharacterizescovid19pneumonia
AT haykarenl macrophageattackculminatinginmicrothrombosescharacterizescovid19pneumonia